Source-backed explainers
44 focused reports on court timelines, changing case counts, scientific evidence, labels, and settlement posture—each built around primary documents.
Court timeline
A dated, source-led account of MDL 3140—from its February 2025 creation through the June 2026 global-agreement disclosure and the next scheduled expert-evidence hearing.
Docket data
Verified JPML snapshots for MDL 3140, with a plain-English explanation of pending versus historical actions and why docket growth cannot predict outcomes.
Settlement status
The court has confirmed a global agreement for some pending MDL plaintiffs. Its terms are not public, it will not resolve every case, and expert litigation is continuing.
Evidence review
A careful reading of the French national study, later U.S. research and the FDA label—without turning population associations into an individual diagnosis or legal conclusion.
FDA label history
What FDA-approved labels from 2010, 2024 and 2025 actually say—and why a label change is important without being a court finding of liability.
Court timeline
A dated guide to the federal gastrointestinal-injury proceeding, from the February 2024 transfer order to 2026 expert and summary-judgment scheduling.
Docket data
Four dated JPML snapshots trace MDL 3094 from 1,521 to 3,848 pending actions, while keeping the newer NAION docket and state cases out of the total.
Evidence review
Delayed gastric emptying is an intended pharmacologic effect. Gastroparesis is a clinical disorder. Here is how trials, observational studies and current FDA labels fit together.
Talc litigation timeline
The federal talc docket has moved through centralization, expert-evidence rulings, three bankruptcy attempts, and a renewed Rule 702 review. This dated timeline separates those procedural events from state trials, settlements, and scientific findings.
Roblox litigation timeline
The Roblox child sexual exploitation and assault MDL is new, fast-moving, and distinct from the older social-media addiction docket. Here are the dated court events without turning allegations into findings.
Parent guide to MDL 3166
MDL 3166 coordinates federal lawsuits involving deeply sensitive allegations about minors. This parent-focused guide explains the process, privacy orders, records, and limits of what a public case page can tell you.
MDL comparison
MDL 3047 and MDL 3166 both concern alleged harms to minors and can involve overlapping platforms. One centers on allegedly addictive social-media design; the other centers on alleged grooming, exploitation, and assault through Roblox.
Hair relaxer timeline
Research on uterine and ovarian cancer triggered thousands of lawsuits, but the scientific studies and MDL orders answer different questions. This timeline tracks both without treating allegations as findings.
Hair relaxer evidence
Several prospective cohorts have reported associations involving uterine, ovarian, breast, and selected non-reproductive cancers. The results are not interchangeable, and none can identify the cause of one person's diagnosis on its own.
Talc docket data
MDL 2738 grew from 58,205 pending federal actions in January 2025 to 68,435 in July 2026. The trend is real, but it does not measure state cases, validated claims, scientific strength, settlement value, or payment timing.
Talc settlement mechanics
Three corporate bankruptcy efforts sought a broad resolution of talc claims. None produced a confirmed global personal-injury plan. This guide separates those rejected proposals from state consumer settlements, individual resolutions, and the still-active federal MDL.
AFFF litigation chronology
A dated, source-led guide to MDL 2873, from federal centralization through water-system settlements and the still-developing personal-injury bellwether process. Status verified July 10, 2026.
AFFF claim types explained
The AFFF MDL contains public-water, personal-injury, property, and other claims. This guide explains why a utility settlement cannot be used as a payout forecast for an individual illness claim.
Paraquat litigation chronology
A source-checked chronology of MDL 3004, including the abandoned first bellwether program, plaintiff-screening orders, and the limited facts made public about a 2025 master settlement agreement.
Federal and state litigation
Roundup litigation runs on two tracks. This guide separates MDL 2741 from state cases, explains what a bellwether can prove, and shows why nationwide case and payout claims are often unreliable.
Settlement process guide
MDL 2846 has a qualified settlement fund and court-supervised administration, but its public orders do not publish a universal payout grid. Here is how the process fits together.
Paragard litigation chronology
A dated guide to the federal Paragard breakage litigation, from centralization in 2020 through case-specific limitation rulings and the latest public bellwether schedule reviewed.
Suboxone evidence review
FDA recognizes serious dental events with buprenorphine medicines dissolved in the mouth, while the federal litigation still tests product, exposure, causation, and warning evidence case by case.
Implanted port evidence review
Implanted ports can fracture, migrate, thrombose, or become infected for multiple reasons. This guide separates known device complications, specific FDA records, and the allegations being tested in Bard MDL 3081.
Evidence review
Case-control studies, prospective cohorts, laboratory evidence, and regulatory testing answer different questions. This review explains the signal, the uncertainty, and the gap between population research and an individual claim.
Docket data
MDL 3060 grew while thousands of actions also left the active inventory. These dated JPML figures show the scale without turning docket arithmetic into settlements or scientific conclusions.
Docket data
The Roblox child-exploitation MDL doubled from 85 to 170 pending actions during the first half of 2026. Here is what each official snapshot counts—and what it cannot establish.
Vision injury litigation
MDL 3163 is separate from the gastrointestinal GLP-1 litigation. Its central question is whether specified medicines can cause NAION—a rare optic-nerve event for which current studies do not all agree.
FDA label history
Ozempic, Wegovy, Mounjaro, and Zepbound do not share one label. This timeline explains major approvals and safety-language changes without treating a revision as proof of an individual injury.
Court order guide
MDL 3140's orders tell a more useful story than its raw case count. They show how the court tests product use, injury documentation, preemption, expert evidence, and a disclosed agreement that does not cover every case.
Litigation timeline
Ten years of Roundup litigation produced expert rulings, bellwether verdicts, private inventory agreements, and continuing scientific disagreement. This timeline keeps those events in their proper lanes.
PPI litigation chronology
A careful chronology of the PPI kidney-injury litigation, from the studies that sharpened the warning debate to federal centralization, bellwether planning, and the July 2026 court inventory.
PPI kidney evidence
A reader-first evidence review of acute interstitial nephritis, chronic kidney disease research, and the records needed to assess a medication history without turning association into proof.
Bair Hugger chronology
MDL 2666 did not move in a straight line. This chronology explains the 2015 centralization, first defense verdict, 2019 expert ruling, 2021 reversal, and the docket's later case-screening phase.
Forced-air warming evidence
The infection question spans engineering, microbiology, orthopedics, and epidemiology. This guide explains what each evidence type contributes—and what no single study can establish.
Cook IVC filter chronology
A source-led timeline of Cook Celect and Günther Tulip filter litigation that keeps FDA clearance, clinical studies, MDL allegations, and current case counts in their proper lanes.
IVC filter evidence
The words used in an imaging report are not interchangeable. This evidence guide explains major IVC-filter findings, their possible clinical significance, and the proof needed before assigning a cause.
Bard port litigation chronology
A dated guide to MDL 3081 that distinguishes implanted-port allegations and trial scheduling from separate Bard recalls, PICC products, and actual case outcomes.
Bard docket data
Four verified JPML snapshots show a large federal docket moving from growth to gradual decline, but the count alone cannot identify who settled, who was dismissed, or what any claim may be worth.
AFFF docket data
Verified federal snapshots reveal a docket reshaped by both new filings and resolved public-water claims, while personal-injury work continues on a separate procedural track.
Paraquat docket data
The official numbers show a docket that kept growing through a major expert ruling and a later settlement agreement for certain claims—not a universal resolution.
Paragard docket data
Four official snapshots track the federal breakage docket from 2,736 to 4,111 pending actions while preserving the distinction between filings, active cases, and proven injuries.
Suboxone court timeline
A source-led chronology of MDL 3092, including the FDA warning, centralization, census screening, selected-case development, and the latest public court orders.
Suboxone docket data
Verified JPML snapshots show rapid early growth followed by a nearly flat 2026 count, while court orders explain why totals alone cannot measure claim quality or settlement progress.
